Editorial Expression of Concern: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts
Saved in:
Main Authors: | Hichame Id Boufker, Laurence Lagneaux, Mehdi Najar, Martine Piccart, Ghanem Ghanem, Jean-Jacques Body, Fabrice Journé |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Cancer |
Online Access: | https://doi.org/10.1186/s12885-025-13460-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Haemorrhagic Colitis Caused by Dasatinib
by: Nishant Patodi, et al.
Published: (2012-01-01) -
Pulsed Electromagnetic Field Regulates MicroRNA 21 Expression to Activate TGF-β Signaling in Human Bone Marrow Stromal Cells to Enhance Osteoblast Differentiation
by: Nagarajan Selvamurugan, et al.
Published: (2017-01-01) -
Effects of lipoxygenase metabolites of arachidonic acid on the growth of human mononuclear marrow cells and marrow stromal cell cultures
by: V. Desplat, et al.
Published: (1998-01-01) -
Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy
by: Makoto Nishimori, et al.
Published: (2018-01-01) -
Influence of Chronic Alcohol Use on Osteoblastic Differentiation of Bone Marrow Cells, Bone Properties, and Hepatic and Renal Morphology of Rats
by: Michelle Cardoso de Sousa, et al.
Published: (2018-01-01)